HMS in the News
Recent Releases
Reducing the Health Harms of Incarceration
Aspen Health Strategy Group
This Aspen Health Strategy Group report offers five big ideas for tackling systemic issues at the intersection of incarceration and health. Action steps to reduce the harm: repeal the Medicaid exclusion for this population, prioritize health in correctional systems, upgrade quality standards of carceral health, coordinate care within and outside carceral settings, and dramatically reduce the level and consequences of incarceration. Background papers provide a fuller context for these ideas.
Breakthrough Cures, Blockbuster Costs: Future Directions
Health, Medicine & Society
Published by Blue Cross Blue Shield Association and HMS, this report examines advanced therapies—biomedical breakthroughs that often treat rare conditions and can transform or even save a patient’s life—that tend to come with extremely high price tags. By 2031, as many as 90 gene and cellular therapies are expected to be approved for use by 550,000 patients, at an annual acquisition cost of $30 billion. A framework for ensuring that high-cost medicines for rare conditions are affordable and accessible to patients emerged from a convening co-chaired by two former U.S. Food and Drug Administration (FDA) commissioners, Scott Gottlieb and Margaret Hamburg.
